EMPIRE CONSULTING GROUP

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Pharmacy Benefit Manager Reform Act. Issues related to 340B. Most-Favored-Nation prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.